Abstract:All presently available replication-competent proviral clones of human immunodeficiency virus type 1 (HIV-1) are derived from cell culture-amplified virus. Since tissue culture is highly selective for viral strains with an in vitro growth advantage, such clones may not be representative of the biologically relevant virus present in vivo. In this study, we report the molecular cloning and genotypic characterization of 10 HIV-1 genomes directly from uncultured brain tissue of a patient with AIDS dementia complex. Targeting unintegrated circular HIV-1 molecules for recombinant lambda phage cloning, we obtained four full-length genomes with one or two long terminal repeats (LTRs), three defective genomes with internal deletions, two rearranged genomes with inverted LTR sequences, and one integrated proviral half with flanking cellular sequences. Nucleotide sequence analysis of these clones demonstrated chromosomal integration, circle formation, genomic inversion, and LTR-mediated autointegration of HIV-1 genomes in vivo. Comparison of a 510-bp hypervariable envelope region among 8 lambda phage-derived and 12 polymerase chain reaction-derived clones from the same brain specimen identified a predominant viral form as well as genetically divergent variants. Variability among 19 of 20 clones ranged between 0.2 and 1.2%. One clone exhibited 8.2% nucleotide sequence differences consisting almost exclusively of G-to-A changes. Transfection of the four full-length HIV-1 genomes identified one clone (YU-2) as replication competent and exhibiting growth characteristics similar to those of tissue culture-derived macrophage tropic strains of HIV-1. These results demonstrate, for the first time, that replication-competent HIV-1 genomes, complex mixtures of defective viral forms, and chromosomally integrated provirus persist in vivo. In addition, the brain-derived viral clones are expected to prove valuable for future studies of macrophage and neurotropism as well as for the analysis of other viral properties that are subject to in vitro selection pressures.

A High-Throughput Method for Cloning and Sequencing Human Immunodeficiency Virus Type 1 Integration Sites

A High-Throughput Method for Cloning and Sequencing HIV-1 Integration Sites

A quantitative assay for HIV DNA integration in vivo

Droplet microfluidic sequencing of HIV genomes and integration sites

Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent Cd4(+) T Cells

High Throughput Functional Analysis of HIV-1 Env Genes Without Cloning.

Molecular genetics and target site specificity of retroviral integration.

393. Site-Directed Integration in Human Genome by Lentiviral Vectors Containing HIV-1 Integrase/Polydactyl Zinc Finger Fusion Proteins

Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis.

Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy

Human T-cell Leukemia Virus Type 1 Integration Target Sites in the Human Genome: Comparison with Those of Other Retroviruses.

Central Core Domain of Retroviral Integrase Is Responsible for Target Site Selection

Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes

Rigrag: High-Resolution Mapping of Genic Targeting Preferences During HIV-1 Integration in Vitro and in Vivo

Assessment of the susceptibility of mutant HIV-1 to antiviral agents.

Physical Principles of Retroviral Integration in the Human Genome

Role of the Nonspecific DNA-binding Region and Α Helices Within the Core Domain of Retroviral Integrase in Selecting Target DNA Sites for Integration

High-throughput Sequencing Identifies HIV-1-replication- and Latency-Related Mirnas in CD4+ T Cell Lines.

Quantitation of HIV DNA integration: effects of differential integration site distributions on Alu-PCR assays

Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses

Site-specific integration of retroviral DNA in human cells using fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc-finger protein E2C.